“Our treatment focuses on hematopoietic cell transplantation (HCT) — a proven method for treating
lymphoma, leukemia and other diseases that affect the bone marrow. Commonly, these procedures are refered to as bone marrow transplants (BMT) because the cells were collected directly from inside the bone, which was more invasive. Today, medical advances allow these same cells to be collected from the bloodstream instead, making the process much less invasive. We will use BMT throughout our materials since it’s more widely recognized and understood. Both terms can be used interchangeably.
A bone marrow transplant (BMT) replaces damaged or diseased bone marrow with healthy cells, allowing the body to produce normal blood cells again. For dogs with lymphoma, this is the only curative treatment available. At CTAC, our team has extensive experience performing BMTs in both small and large dogs. Although these procedures are complex, their outcomes can be life-changing — giving many dogs with lymphoma the chance for a longer life with their families.
Each transplant is carefully planned to meet the specific needs of the patient, beginning with the selection of the stem cell source.

Uses the patient’s own stem cells

Uses stem cells from a matched donor

While both allogeneic and autologous BMT carries some risks, they remain the most promising treatments that can cure dogs with B- and T-cell lymphoma. Success depends upon many factors including the type of lymphoma, the dog’s overall health, if remission before the procedure is achieved, and what type of BMT is used. BMT is now covered my many major pet insurance companies.